TASLY PHARMACEUTICA GROUPTASLY PHARMACEUTICA GROUPTASLY PHARMACEUTICA GROUP

TASLY PHARMACEUTICA GROUP

No trades
See on Supercharts
Market capitalization
‪22.57 B‬CNY
‪1.07 B‬CNY
‪8.55 B‬CNY
‪710.36 M‬
Beta (1Y)
1.13

About TASLY PHARMACEUTICA GROUP

CEO
Jing Su
Headquarters
Tianjin
Website
Employees (FY)
‪9.22 K‬
Founded
1994
ISIN
CNE000001C81
FIGI
BBG000LTYZ52
Tasly Pharmaceutical Group Co., Ltd. engages in the development, manufacture and distribution of pharmaceutical products. Its products include herbal medicines, chemical medicines, pharmaceutical substances, herbal extract and tea products, cosmetics and daily hygiene products, and medical equipment. The company was founded on May 10, 1994 and is headquartered in Tianjin, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 600535 is 15.22 CNY — it has decreased by 1.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange TASLY PHARMACEUTICA GROUP stocks are traded under the ticker 600535.
TASLY PHARMACEUTICA GROUP is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
600535 stock is 1.98% volatile and has beta coefficient of 1.13. Check out the list of the most volatile stocks — is TASLY PHARMACEUTICA GROUP there?
One year price forecast for TASLY PHARMACEUTICA GROUP has a max estimate of 17.30 CNY and a min estimate of 9.50 CNY.
600535 earnings for the last quarter are 0.22 CNY whereas the estimation was 0.23 CNY which accounts for −4.35% surprise. Estimated earnings for the next quarter are 0.16 CNY. See more details about TASLY PHARMACEUTICA GROUP earnings.
TASLY PHARMACEUTICA GROUP revenue for the last quarter amounts to ‪1.94 B‬ CNY despite the estimated figure of ‪6.22 B‬ CNY. In the next quarter revenue is expected to reach ‪6.22 B‬ CNY.
Yes, you can track TASLY PHARMACEUTICA GROUP financials in yearly and quarterly reports right on TradingView.
600535 stock has fallen by 2.75% compared to the previous week, the month change is a 11.51% fall, over the last year TASLY PHARMACEUTICA GROUP has showed a 0.85% decrease.
600535 net income for the last quarter is ‪38.64 M‬ CNY, while the quarter before that showed ‪325.33 M‬ CNY of net income which accounts for −88.12% change. Track more TASLY PHARMACEUTICA GROUP financial stats to get the full picture.
Today TASLY PHARMACEUTICA GROUP has the market capitalization of ‪22.65 B‬, it has decreased by 2.42% over the last week.
Yes, 600535 dividends are paid annually. The last dividend per share was 0.33 CNY. As of today, Dividend Yield (TTM)% is 2.17%. Tracking TASLY PHARMACEUTICA GROUP dividends might help you take more informed decisions.
Like other stocks, 600535 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TASLY PHARMACEUTICA GROUP stock right from TradingView charts — choose your broker and connect to your account.
600535 reached its all-time high on May 27, 2015 with the price of 41.32 CNY, and its all-time low was 2.10 CNY and was reached on Mar 7, 2006.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪9.22 K‬ employees. See our rating of the largest employees — is TASLY PHARMACEUTICA GROUP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TASLY PHARMACEUTICA GROUP technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TASLY PHARMACEUTICA GROUP stock shows the neutral signal. See more of TASLY PHARMACEUTICA GROUP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TASLY PHARMACEUTICA GROUP future price: according to them, 600535 price has a max estimate of 17.30 CNY and a min estimate of 9.50 CNY. Read a more detailed TASLY PHARMACEUTICA GROUP forecast: see what analysts think of TASLY PHARMACEUTICA GROUP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TASLY PHARMACEUTICA GROUP EBITDA is ‪1.92 B‬ CNY, and current EBITDA margin is 22.88%. See more stats in TASLY PHARMACEUTICA GROUP financial statements.